p21 response to DNA damage induced by genistein and etoposide in human lung cancer cells

被引:33
作者
Ding, H
Duan, WR
Zhu, WG
Ju, R
Srinivasan, K
Otterson, GA
Villalona-Calero, MA [1 ]
机构
[1] Ohio State Univ, Arthur James Canc Hosp, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Richard Solove Res Inst, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[4] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA
关键词
p21(WAF1)/(Cip1); p53; DNA damage response; genistein; etoposide; ATM; ATR; DNA-PKs;
D O I
10.1016/S0006-291X(03)00873-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p21(WAFI/Cip1) gene plays a central role in cell cycle regulation. Here we show that topoisomerase II inhibitors, genistein and etoposide, induce p2(WAF1/Cip1) expression mainly in a p53-dependent manner in human lung cancer cell line A549. However, although p53 accumulated, p21(WAF1/Cip1) expression did not depend on the level of Ser15 phosphorylation of p53. Caffeine, an ataxia telangiectasia-mutated (ATM), and ATM- and Rad3-related kinase (ATR) inhibitor, abrogated genistein-induced p21(WAF1/Cip1) and largely blocked etoposide-induced p21(WAF1/Cip1) expression. Wortmannin, an ATM- and DNA-dependent protein kinase inhibitor, partially inhibited p21(WAF1/Cip1) expression induced by genistein and etoposide, whereas UCN-01, a Chk1 inhibitor, partially blocked etoposide, but not genistein-induced p21(WAF1/Cip1) expression. These data suggest that both genistein and etoposide induce p21(WAF1/Cip1) expression in a p53-dependent manner. Genistein appears to stimulate p21(WAF1/Cip1) expression through p53 via ATM, whereas etoposide may activate both ATM and ATR pathways. Our results suggest different mechanisms participate in genistein and etoposide induced p21(WAF1/Cip1) expression. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:950 / 956
页数:7
相关论文
共 41 条
[1]   Cell cycle checkpoint signaling through the ATM and ATR kinases [J].
Abraham, RT .
GENES & DEVELOPMENT, 2001, 15 (17) :2177-2196
[2]   The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[3]  
ARTUSO M, 1995, ONCOGENE, V11, P1427
[4]   EXPRESSION, DOMAIN-STRUCTURE, AND ENZYMATIC-PROPERTIES OF AN ACTIVE RECOMBINANT HUMAN DNA TOPOISOMERASE II-BETA [J].
AUSTIN, CA ;
MARSH, KL ;
WASSERMAN, RA ;
WILLMORE, E ;
SAYER, PJ ;
WANG, JC ;
FISHER, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (26) :15739-15746
[5]   Enhanced phosphorylation of p53 by ATN in response to DNA damage [J].
Banin, S ;
Moyal, L ;
Shieh, SY ;
Taya, Y ;
Anderson, CW ;
Chessa, L ;
Smorodinsky, NI ;
Prives, C ;
Reiss, Y ;
Shiloh, Y ;
Ziv, Y .
SCIENCE, 1998, 281 (5383) :1674-1677
[6]  
Busby EC, 2000, CANCER RES, V60, P2108
[7]  
Cappelletti V, 2000, J CELL BIOCHEM, V79, P594, DOI 10.1002/1097-4644(20001215)79:4<594::AID-JCB80>3.3.CO
[8]  
2-W
[9]  
CHEN GL, 1984, J BIOL CHEM, V259, P3560
[10]   p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells [J].
Choi, YH ;
Lee, WH ;
Park, KY ;
Zhang, LJ .
JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (02) :164-173